Cart
sales@molnova.com
Imidacloprid
CAS No. 138261-41-3
Imidacloprid( —— )
Catalog No. M20535 CAS No. 138261-41-3
Imidacloprid is a systemic chloronicotinyl insecticide which can be effectively used in agriculture to control pests .
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 43 | In Stock |
|
| 50MG | 36 | In Stock |
|
| 100MG | 49 | In Stock |
|
| 200MG | 75 | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameImidacloprid
-
NoteResearch use only, not for human use.
-
Brief DescriptionImidacloprid is a systemic chloronicotinyl insecticide which can be effectively used in agriculture to control pests .
-
DescriptionImidacloprid is a systemic chloronicotinyl insecticide which can be effectively used in agriculture to control pests .
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
RecptorOthers
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number138261-41-3
-
Formula Weight255.66
-
Molecular FormulaC9H10ClN5O2
-
Purity>98% (HPLC)
-
SolubilityDMSO:300 mg/mL (1173.43 mM)
-
SMILES[O-][N+](=O)NC1=NCCN1Cc1ccc(Cl)nc1
-
Chemical Name1-(6-Chloropyridin-3-ylmethyl)-N-nitroimidazolidin-2-ylidenamine
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Kim J Park Y Yoon K S et al. Imidacloprid a neonicotinoid insecticide induces insulin resistance[J]. The Journal of Toxicological Sciences 2013 38(5):655-660.
molnova catalog
related products
-
680C91
680C91 is a potent and selective inhibitor of TDO, and its Ki is 51 nM.
-
Su1498
SU 1498 is a selective inhibitor of the receptor tyrosine kinase VEGF receptor 2 (VEGFR2, aka FLK1; IC50 = 700 nM).
-
Nogo-66 (1-40)
Peptide fragment corresponding to residues 1 - 40 of Nogo-66, the domain of the myelin protein Nogo that inhibits axonal outgrowth. Acts as a competitive antagonist at the Nogo-66 receptor (NgR); blocks Nogo-66- and CNS myelin-induced inhibition of axonal growth, but does not reduce myelin-associated glycoprotein (MAG) inhibition of neurite outgrowth in vitro. Promotes regeneration of hemisected spinal axons and locomotor recovery following spinal injury in vivo.
